• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有特定错配修复基因缺陷的人类癌细胞系中次黄嘌呤磷酸核糖转移酶(hprt)基因座的突变率。

Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects.

作者信息

Glaab W E, Tindall K R

机构信息

Curriculum in Toxicology, University of North Carolina, Chapel Hill 27599, USA.

出版信息

Carcinogenesis. 1997 Jan;18(1):1-8. doi: 10.1093/carcin/18.1.1.

DOI:10.1093/carcin/18.1.1
PMID:9054582
Abstract

Spontaneous mutation rates at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus were measured in human cancer cell lines defective in the mismatch repair (MMR) genes hMLH1, hPMS2, or GTBP, as well as in a cell line carrying mutations in both hMLH1 and hPMS2. The mutation rate was determined by quantitating mutant frequency increases within a single culture as a function of cell division. These MMR-deficient cell lines exhibited a 50- to 750-fold increase in mutation rate relative to a MMR-proficient cancer cell line. From lowest to highest, the spontaneous mutation rates relative to the MMR-gene defects studied here are as follows: hMLH1- < GTBP- < hPMS2- < hMLH1- / hPMS2-. In addition, a cell line in which MMR was restored by chromosome transfer exhibited a mutation rate 12-fold below the MMR-deficient parental cell line. These data support the notion that MMR plays an important role in controlling the rate of spontaneous mutation and suggest that different MMR-gene defects may vary in their ability to repair different types of DNA mismatches, thus leading to measurable quantitative differences in spontaneous mutagenesis. Furthermore, a difference in mutation rates was observed between a hPMS2-defective cell line (3.1 x 10(-5) mutations/cell/generation) and two hMLH1-defective cell lines (4.0 x 10(-6) and 7.3 x 10(-6) mutations/cell/generation). Assuming the hPMS2- and hMLH1-gene products only function in the proposed hMutL alpha heterodimer, then defects in either gene should yield comparable mutation rates. These data suggest that hPMS2 plays a critical role in MMR, while additional hMLH1 homologues or hPMS2 alone may function to partially complement defects in hMLH1.

摘要

在错配修复(MMR)基因hMLH1、hPMS2或GTBP存在缺陷的人类癌细胞系,以及同时携带hMLH1和hPMS2突变的细胞系中,测量了次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(hprt)位点的自发突变率。通过定量单个培养物中突变频率随细胞分裂的增加来确定突变率。相对于具有MMR功能的癌细胞系,这些MMR缺陷的细胞系的突变率增加了50至750倍。从最低到最高,相对于此处研究的MMR基因缺陷,自发突变率如下:hMLH1缺陷型 < GTBP缺陷型 < hPMS2缺陷型 < hMLH1 / hPMS2双缺陷型。此外,通过染色体转移恢复MMR功能的细胞系的突变率比MMR缺陷的亲代细胞系低12倍。这些数据支持了MMR在控制自发突变率中起重要作用的观点,并表明不同的MMR基因缺陷在修复不同类型DNA错配的能力上可能存在差异,从而导致自发诱变中可测量的定量差异。此外,在一个hPMS2缺陷的细胞系(3.1×10⁻⁵个突变/细胞/代)和两个hMLH1缺陷的细胞系(4.0×10⁻⁶和7.3×10⁻⁶个突变/细胞/代)之间观察到了突变率的差异。假设hPMS2和hMLH1基因产物仅在所提出的hMutLα异源二聚体中起作用,那么任一基因的缺陷都应产生相当的突变率。这些数据表明hPMS2在MMR中起关键作用,而额外的hMLH1同源物或单独的hPMS2可能起到部分弥补hMLH1缺陷的作用。

相似文献

1
Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects.具有特定错配修复基因缺陷的人类癌细胞系中次黄嘌呤磷酸核糖转移酶(hprt)基因座的突变率。
Carcinogenesis. 1997 Jan;18(1):1-8. doi: 10.1093/carcin/18.1.1.
2
Mismatch repair deficiency in hematological malignancies with microsatellite instability.伴有微卫星不稳定的血液系统恶性肿瘤中的错配修复缺陷
Oncogene. 2002 Aug 22;21(37):5758-64. doi: 10.1038/sj.onc.1205695.
3
Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.错配修复缺陷的人类癌细胞系对6-硫鸟嘌呤的抗性与次黄嘌呤磷酸核糖转移酶(HPRT)基因座诱导突变的增加相关。
Carcinogenesis. 1998 Nov;19(11):1931-7. doi: 10.1093/carcin/19.11.1931.
4
Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.用于遗传性hMLH1和hMSH2变异功能分析的瞬时错配修复基因转染
Gut. 2002 Nov;51(5):677-84. doi: 10.1136/gut.51.5.677.
5
Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines.胃癌细胞系中DNA错配修复蛋白的改变及微卫星不稳定性水平
Lab Invest. 2004 Jul;84(7):915-22. doi: 10.1038/labinvest.3700117.
6
Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.通过非放射性多重逆转录-聚合酶链反应同时检测正常和癌细胞系中五个选定的人类错配修复基因的表达。
Pathobiology. 1997;65(6):293-300. doi: 10.1159/000164141.
7
The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer.遗传性非息肉病性结直肠癌中人类MutL同源物的相互作用。
J Biol Chem. 1999 Mar 5;274(10):6336-41. doi: 10.1074/jbc.274.10.6336.
8
Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.错配修复基因的突变参与人类乳腺上皮细胞的肿瘤转化。
Int J Oncol. 2003 Aug;23(2):411-9.
9
Loss of DNA mismatch repair in acquired resistance to cisplatin.顺铂获得性耐药中DNA错配修复的缺失
Cancer Res. 1996 Jul 1;56(13):3087-90.
10
Characterization of distinct human endometrial carcinoma cell lines deficient in mismatch repair that originated from a single tumor.源自单一肿瘤的错配修复缺陷的不同人子宫内膜癌细胞系的特征分析。
J Biol Chem. 1998 Oct 9;273(41):26662-9. doi: 10.1074/jbc.273.41.26662.

引用本文的文献

1
SET facilitates immune escape of microsatellite stability colorectal cancer by inhibiting c-Myc degradation.SET通过抑制c-Myc降解促进微卫星稳定型结直肠癌的免疫逃逸。
Cancer Sci. 2025 Jan;116(1):29-43. doi: 10.1111/cas.16368. Epub 2024 Oct 17.
2
High-content microscopy reveals a morphological signature of bortezomib resistance.高内涵显微镜揭示硼替佐米耐药的形态特征。
Elife. 2023 Sep 27;12:e91362. doi: 10.7554/eLife.91362.
3
High-content microscopy reveals a morphological signature of bortezomib resistance.高内涵显微镜分析揭示了硼替佐米耐药的形态学特征。
bioRxiv. 2023 May 2:2023.05.02.539137. doi: 10.1101/2023.05.02.539137.
4
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors.BRD4 抑制会损害 DNA 错配修复,诱导错配修复突变特征,并在 MMR 功能正常的肿瘤中产生对免疫检查点阻断的治疗敏感性。
J Immunother Cancer. 2023 Apr;11(4). doi: 10.1136/jitc-2022-006070.
5
Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC.依赖变构的耐药性:一种P环僵直Eg5突变体对STLC的变构抑制具有抗性。
Front Oncol. 2022 Oct 12;12:965455. doi: 10.3389/fonc.2022.965455. eCollection 2022.
6
Involvement of APOBEC3B in mutation induction by irradiation.APOBEC3B 在辐射诱导突变中的作用。
J Radiat Res. 2020 Nov 16;61(6):819-827. doi: 10.1093/jrr/rraa069.
7
Chemical strategies to overcome resistance against targeted anticancer therapeutics.克服靶向抗癌疗法耐药性的化学策略。
Nat Chem Biol. 2020 Aug;16(8):817-825. doi: 10.1038/s41589-020-0596-8. Epub 2020 Jul 21.
8
Distinct Mechanisms of Resistance to a CENP-E Inhibitor Emerge in Near-Haploid and Diploid Cancer Cells.近单倍体和二倍体癌细胞中出现对CENP-E抑制剂的不同耐药机制。
Cell Chem Biol. 2020 Jul 16;27(7):850-857.e6. doi: 10.1016/j.chembiol.2020.05.003. Epub 2020 May 21.
9
Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer.单染色体增益可作为结肠癌转移抑制因子和促进因子。
Dev Cell. 2020 Feb 24;52(4):413-428.e6. doi: 10.1016/j.devcel.2020.01.034.
10
Reviving rare chicken breeds using genetically engineered sterility in surrogate host birds.利用基因工程使代孕宿主鸟不育来复活稀有鸡种。
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):20930-20937. doi: 10.1073/pnas.1906316116. Epub 2019 Oct 1.